-
1Academic Journal
Συγγραφείς: S. V. Popov, L. N. Maslov, A. V. Mukhomedzyanov, A. S. Slidnevskaya, A. Kan, N. V. Naryzhnaya, Yu. G. Birulina, T. V. Lasukova, Yu. K. Podoxenov, С. В. Попов, Л. Н. Маслов, А. В. Мухомедзянов, А. С. Слидневская, А. Кан, Н. В. Нарыжная, Ю. Г. Бирулина, Т. В. Ласукова, Ю. К. Подоксенов
Συνεισφορές: The study was supported by the Russian Science Foundation grant No. 23-65-10017. The section on post-infarction cardiac remodeling was prepared in the framework of the state assignment 122020300042-4, Работа выполнена при финансовой поддержке гранта Российского научного фонда №2365-10017. Раздел, посвященный постинфарктному ремоделированию сердца, подготовлен в рамках государственного задания 122020300042-4
Πηγή: Siberian Journal of Clinical and Experimental Medicine; Том 40, № 1 (2025); 11-18 ; Сибирский журнал клинической и экспериментальной медицины; Том 40, № 1 (2025); 11-18 ; 2713-265X ; 2713-2927
Θεματικοί όροι: адреномедуллин, peptides, ischemia/reperfusion, post-infarction cardiac remodeling, adrenomedullin, пептиды, ишемия / реперфузия, постинфарктное ремоделирование сердца
Περιγραφή αρχείου: application/pdf
Relation: https://www.sibjcem.ru/jour/article/view/2628/1043; Currey E.M., Falconer N., Isoardi K.Z., Barras M. Impact of pharmacists during in-hospital resuscitation or medical emergency response events: A systematic review. Am. J. Emerg. Med. 2024;75:98–110. https://doi.org/10.1016/j.ajem.2023.10.020; Ashraf S., Farooq U., Shahbaz A., Khalique F., Ashraf M., Akmal R. et al. Factors responsible for worse outcomes in STEMI patients with early vs delayed treatment presenting in a tertiary care center in a third world country. Curr. Probl. Cardiol. 2024;49(1_Pt_B):102049. https://doi.org/10.1016/j.cpcardiol.2023.102049; Nanavaty D., Sinha R., Kaul D., Sanghvi A., Kumar V., Vachhani B. et al. Impact of COVID-19 on acute myocardial infarction: A national inpatient sample analysis. Curr. Probl. Cardiol. 2024;49(1_Pt_A):102030. https://doi.org/10.1016/j.cpcardiol.2023.102030; Hti Lar Seng N.S., Zeratsion G., Pena Zapata O.Y., Tufail M.U., Jim B. Utility of cardiac troponins in patients with chronic kidney disease. Cardiol. Rev. 2024;32(1):62–70. https://doi.org/10.1097/CRD.0000000000000461; Luo Q., Sun W., Li Z., Sun J., Xiao Y., Zhang J. et al. Biomaterialsmediated targeted therapeutics of myocardial ischemia-reperfusion injury. Biomaterials. 2023;303:122368. https://doi.org/10.1016/j.biomaterials.2023.122368; Мотова А.В., Каретникова В.Н., Осокина А.В., Поликутина О.М., Барбараш О.Л. Инфаркт миокарда 2-го типа: особенности диагностики в реальной клинической практике. Сибирский журнал клинической и экспериментальной медицины. 2022;37(3):75–82. https://doi.org/10.29001/2073-8552-2022-37-3-75-82; Вышлов Е.В., Алексеева Я.В., Усов В.Ю., Мочула О.В., Рябов В.В. Синдром микрососудистого повреждения миокарда у пациентов с первичным инфарктом миокарда с подъемом сегмента ST: распространенность и связь с клиническими характеристиками. Сибирский журнал клинической и экспериментальной медицины. 2022;37(1):36–46. https://doi.org/10.29001/2073-8552-2021-36-4-36-46; Li M., Hu L., Li L. Research progress of intra-aortic balloon counterpulsation in the treatment of acute myocardial infarction with cardiogenic shock: A review. Medicine (Baltimore). 2023;102(49):e36500. https://doi.org/10.1097/MD.0000000000036500; Maslov L.N., Popov S.V., Mukhomedzyanov A.V., Naryzhnaya N.V., Voronkov N.S., Ryabov V.V. et al. Reperfusion cardiac injury: Receptors and the signaling mechanisms. Cur. Cardiol. Rev. 2022;18(5):63–79. https://doi.org/10.2174/1573403X18666220413121730; Reimer K.A., Jennings R.B. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. Lab. Invest. 1984;51(6):655–666.; Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H. et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 1993a;192(2):553–560. https://doi.org/10.1006/bbrc.1993.1451; Sugo S., Minamino N., Kangawa K., Miyamoto K., Kitamura K., Sakata J. et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem. Biophys. Res. Commun. 1994;201(3):1160–1166. https://doi.org/10.1006/bbrc.1994.1827; Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 1993b; 194(2):720– 725. https://doi.org/10.1006/bbrc.1993.1881; Ishiyama Y., Kitamura K., Ichiki Y., Sakata J., Kida O., Kangawa K. et al. Haemodynamic responses to rat adrenomedullin in anaesthetized spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 1995;22(9):614–618. https://doi.org/10.1111/j.1440-1681.1995.tb02075.x; Meeran K., O'Shea D., Upton P.D., Small C.J., Ghatei M.A., Byfield P.H. et al. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J. Clin. Endocrinol. Metab. 1997;82(1):95–100. https://doi.org/10.1210/jcem.82.1.3656; Sandoval D.A., D'Alessio D.A. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease. Physiol. Rev. 2015;95(2):513–548. https://doi.org/10.1152/physrev.00013.2014; Reed A.B., Lanman B.A., Holder J.R., Yang B.H., Ma J., Humphreys S.C. et al. Half-life extension of peptidic APJ agonists by N-terminal lipid conjugation. Bioorg. Med. Chem. Lett. 2020;30(21):127499. https://doi.org/10.1016/j.bmcl.2020.127499; Naot D., Musson D.S., Cornish J. The activity of peptides of the calcitonin family in bone. Physiol. Rev. 2019;99(1):781–805. https://doi.org/10.1152/physrev.00066.2017; Woolley M.J., Reynolds C.A., Simms J., Walker C.S., Mobarec J.C., Garelja M.L. et al. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs. Biochem. Pharmacol. 2017;142:96–110. https://doi.org/10.1016/j.bcp.2017.07.005; Sekine N., Takano K., Kimata-Hayashi N., Kadowaki T., Fujita T. Adrenomedullin inhibits insulin exocytosis via pertussis toxin-sensitive G protein-coupled mechanism. Am. J. Physiol. Endocrinol. Metab. 2006;291(1):E9–E14. https://doi.org/10.1152/ajpendo.00213.2005; Mittra S. Bourreau J.P. Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytes. Am J. Physiol. Heart Circ. Physiol. 2006;290(5):H1842–H1847. https://doi.org/10.1152/ajpheart.00388.2005; Berenguer C., Boudouresque F., Dussert C., Daniel L., Muracciole X., Grino M. et al. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells. Oncogene. 2008;27(4):506–518. https://doi.org/10.1038/sj.onc.1210656; Bell D., Campbell M., McAleer S.F., Ferguson M., Donaghy L., Harbinson M.T. Endothelium-derived intermedin/adrenomedullin-2 protects human ventricular cardiomyocytes from ischaemiareoxygenation injury predominantly via the AM1 receptor. Peptides. 2016;76:1–13. https://doi.org/10.1016/j.peptides.2015.12.005; Xian X., Sakurai T., Kamiyoshi A., Ichikawa-Shindo Y., Tanaka M., Koyama T. et al. Vasoprotective activities of the adrenomedullin-RAMP2 system in endothelial cells. Endocrinology. 2017;158(5):1359–1372. https://doi.org/10.1210/en.2016-1531; Josiassen J., Frydland M., Holmvang L., Lerche Helgestad O.K., Okkels Jensen L., Goetze J.P. et al. Mortality in cardiogenic shock is stronger associated to clinical factors than contemporary biomarkers reflecting neurohormonal stress and inflammatory activation. Biomarkers. 2020;25(6):506–512. https://doi.org/10.1080/1354750X.2020.1795265; Nagaya N., Nishikimi T., Uematsu M., Yoshitomi Y., Miyao Y., Miyazaki S. et al. Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction. Heart. 1999;81(5):483–487. https://doi.org/10.1136/hrt.81.5.483; Hartopo A.B., Puspitawati I., Anggraeni V.Y. High level of mid-regional proadrenomedullin during ST-segment elevation myocardial infarction is an independent predictor of adverse cardiac events within 90-day follow-up. Medicina (Kaunas). 2022;58(7):861. https://doi.org/10.3390/medicina58070861; Vijay P., Szekely L., Aufiero T.X., Sharp T.G. Coronary sinus adrenomedullin rises in response to myocardial injury. Clin. Sci. (Lond). 1999;96(4):415–420. https://doi.org/10.1042/cs0960415; Oie E., Vinge L.E., Yndestad A., Sandberg C., Grøgaard H.K., Attramadal H. Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation. 2000;101(4):415–422. https://doi.org/10.1161/01.cir.101.4.415; Nagaya N., Nishikimi T., Yoshihara F., Horio T., Morimoto A., Kangawa K. Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000;278(4):R1019–R1026. https://doi.org/10.1152/ajpregu.2000.278.4.R1019; Belloni A.S., Guidolin D., Ceretta S., Bova S., Nussdorfer G.G. Acute effect of ischemia on adrenomedullin immunoreactivity in the rat heart: an immunocytochemical study. Int. J. Mol. Med. 2004;14(1):71–73. https://doi.org/10.3892/ijmm.14.1.71; Hinrichs S., Scherschel K., Krüger S., Neumann J.T., Schwarz M., Yan I. et al. Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction. Proc. Natl. Acad. Sci USA. 2018;115(37):E8727–E8736. https://doi.org/1073/pnas.1721635115; Kato K., Yin H., Agata J., Yoshida H., Chao L., Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am J. Physiol. Heart. Circ. Physiol. 2003;285(4):H1506– H1514. https://doi.org/10.1152/ajpheart.00270.2003; de Miranda D.C., de Oliveira Faria G., Hermidorff M.M., Dos Santos Silva F.C., de Assis L.V.M., Isoldi M.C. Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways. Curr. Vasc. Pharmacol. 2021;19(5):499–524. https://doi.org/10.2174/1570161119666201120160619; Yin H., Chao L., Chao J. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension. 2004;43(1):109–116. https://doi.org/10.1161/01.HYP.0000103696.60047.55; An R., Xi C., Xu J., Liu Y., Zhang S., Wang Y. et al. Intramyocardial injection of recombinant adeno-associated viral vector coexpressing PR39/adrenomedullin enhances angiogenesis and reduces apoptosis in a rat myocardial infarction model. Oxid. Med. Cell. Longev. 2017;2017:1271670. https://doi.org/10.1155/2017/1271670; Naryzhnaya N.V., Maslov L.N., Derkachev I.A., Ma H., Zhang Y., Prasad N.R. et al. The effect of an adaptation to hypoxia on cardiac tolerance to ischemia/reperfusion. J. Biomed. Res. 2022;37(4):230–254. https://doi.org/10.7555/JBR.36.20220125; Moradi M., Mousavi A., Emamgholipour Z., Giovannini J., Moghimi S., Peytam F. et al. Quinazoline-based VEGFR-2 inhibitors as potential antiangiogenic agents: A contemporary perspective of SAR and molecular docking studies. Eur. J. Med. Chem. 2023;259:115626. https://doi.org/10.1016/j.ejmech.2023.115626; Okumura H., Nagaya N., Itoh T., Okano I., Hino J., Mori K. et al. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation. 2004;109(2):242–248. https://doi.org/10.1161/01.CIR.0000109214.30211.7C; Hamid S.A., Baxter G.F. Adrenomedullin limits reperfusion injury in experimental myocardial infarction. Basic Res. Cardiol. 2005;100(5):387– 396. https://doi.org/10.1007/s00395-005-0538-3; Hamid S.A., Baxter G.F. A critical cytoprotective role of endogenous adrenomedullin in acute myocardial infarction. J. Mol. Cell. Cardiol. 2006;41(2):360–363. https://doi.org/10.1016/j.yjmcc.2006.05.017; Hamid S.A., Totzeck M., Drexhage C., Thompson I., Fowkes R.C., Rassaf T. et al. Nitric oxide/cGMP signalling mediates the cardioprotective action of adrenomedullin in reperfused myocardium. Basic Res. Cardiol. 2010;105(2):257–266. https://doi.org/10.1007/s00395-009-0058-7; Nishida H., Sato T., Miyazaki M., Nakaya H. Infarct size limitation by adrenomedullin: protein kinase A but not PI3-kinase is linked to mitochondrial KCa channels. Cardiovasc. Res. 2008;77(2):398–405. https://doi.org/10.1016/j.cardiores.2007.07.015; Torigoe Y., Takahashi N., Hara M., Yoshimatsu H., Saikawa T. Adrenomedullin improves cardiac expression of heat-shock protein 72 and tolerance against ischemia/reperfusion injury in insulin-resistant rats. Endocrinology. 2009;150(3):1450–1455. https://doi.org/10.1210/en.2008-1052; Karakas M., Akin I., Burdelski C., Clemmensen P., Grahn H., Jarczak D. et al. Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, doubleblinded, placebo-controlled, multicentre trial. Lancet Respir. Med. 2022;10(3):247–254. https://doi.org/10.1016/S2213-2600(21)00439-2; Nakamura R., Kato J., Kitamura K., Onitsuka H., Imamura T., Marutsuka K. et al. Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats. Cardiovasc. Res. 2002;56(3):373–380. https://doi.org/10.1016/s0008-6363(02)00594-1; Okumura H., Nagaya N., Kangawa K. Adrenomedullin infusion during ischemia/reperfusion attenuates left ventricular remodeling and myocardial fibrosis in rats. Hypertens. Res. 2003;26_Suppl:S99–S104. https://doi.org/10.1291/hypres.26.s99; Nakamura R., Kato J., Kitamura K., Onitsuka H., Imamura T., Cao Y. et al. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats. Circulation. 2004;110(4):426–431. https://doi.org/10.1161/01.CIR.0000136085.34185.83; Dong W., Yu P., Zhang T., Zhu C., Qi J., Liang J. Adrenomedullin serves a role in the humoral pathway of delayed remote ischemic preconditioning via a hypoxia-inducible factor-1α-associated mechanism. Mol. Med. Rep. 2018;17(3):4547–4553. https://doi.org/10.3892/mmr.2018.8450; Dou L., Lu E., Tian D., Li F., Deng L., Zhang Y. Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism. J. Transl. Int. Med. 2023;11(2):169–177. https://doi.org/10.2478/jtim-2023-0091; Wang X., Jia J.H., Zhang M., Meng Q.S., Yan B.W., Ma Z.Y. et al. Adrenomedullin/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis. FASEB J. 2023;37(10):e23143. https://doi.org/10.1096/fj.202300474R; https://www.sibjcem.ru/jour/article/view/2628
-
2Academic Journal
Συγγραφείς: Кузьмин, Олег, Пугаева, Марина, Жежа, Владислав, Ландарь, Лариса
Θεματικοί όροι: ИНГИБИТОРЫ ВАЗОПЕПТИДАЗ, АДРЕНОМЕДУЛЛИН, НАТРИЙУРЕТИЧЕСКИЕ ПЕПТИДЫ, НЕФРОПРОТЕКТИВНАЯ ТЕРАПИЯ
Περιγραφή αρχείου: text/html
-
3Academic Journal
Πηγή: Обзоры по клинической фармакологии и лекарственной терапии.
Θεματικοί όροι: 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, ИНГИБИТОРЫ ВАЗОПЕПТИДАЗ, АДРЕНОМЕДУЛЛИН, НАТРИЙУРЕТИЧЕСКИЕ ПЕПТИДЫ, НЕФРОПРОТЕКТИВНАЯ ТЕРАПИЯ, 3. Good health
Περιγραφή αρχείου: text/html
